Meet our Trustee: Rob Halliwell
Rob is a Chief Technology Officer based in Manchester, with over 20 years’ experience leading technology, software development and digital transformation.
Search
Search results
SparingVision completes dosing in PRODYGY trial of SPVNO6 for retinitis pigmentosa.
SparingVision have announced this week that they have dosed all participants in their phase 1/2 PRODYGY clinical trial for SPVN06, a gene agnostic therapy aimed at slowing disease progression in Retinitis Pigmentosa (RP).
Fundraising
Raise money to help support people affected by inherited sight loss to lead better lives today and accelerate the search for treatments for the future.
Retina UK set to feature in BBC Lifeline Appeal
Catch up on our BBC Lifeline Appeal from November 2025.
Webinar: Usher syndrome mini series – part two
Professor Mariya Moosajee looks at the latest research, clinical trials and treatment prospects for people affected by Usher’s syndrome.
e-Newsletter – April 2023
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
e-Newsletter December 2025
Our monthly e-Newsletter featuring the latest updates from Retina UK.
Podcast: Eye tests: find out more about what to expect at appointments
The latest podcast from Retina UK.
Fundraising FAQs
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.